Atrial natriuretic peptide and osteopontin are useful markers of cardiac disorders in mice.
Biomarkers are not established for cardiovascular phenotyping in mice. We compared the use of echocardiography with the determination of N-terminal propeptide of the atrial natriuretic peptide (Nt-proANP) and osteopontin (Opn). We measured plasma Nt-proANP and Opn levels in (1) the inbred strains C57BL/6, BALB/c, C3H/He, DBA/2, FVB/N, 129S1/Sv; (2) a surgical model of nonischemic myocardial infarction; and (3) delta-sarcoglycan (Sgcd) and calsarcin 1 [also known as myozenin 2 (Myoz2)] knockout models of cardiomyopathy. Left ventricular function was assessed as fractional shortening (FS) by echocardiography in conscious mice. Plasma Nt-proANP exhibited marked variability and ranged from 0.31 +/- 0.19 (C57BL/6 male mice) to 1.34 +/- 0.43 nmol/l (DBA/2 female mice), depending on sex, age, and genetic background. Opn was less variable than Nt-proANP and was decreased significantly in C3H/He and DBA/2 throughout the 16 wk of study. Nt-proANP increased temporarily in mice with myocardial injury. In contrast, Opn increased in both operated and sham-treated mice. Nt-proANP was inversely correlated with FS and distinguished controls from Sgcd and Myoz2 mutants with 100% sensitivity and 71% specificity. Opn was increased in Sgcd mutants, which exhibited only mildly reduced FS but marked myocardial degeneration and fibrosis. Both of these histologic features were absent in Myoz2 mutants. Nt-proANP is an early marker of cardiac disease and is suitable for age- and sex-matched comparisons between groups of transgenic and matched control mice. Opn is useful to detect inflammatory and degenerative myocardial disorders that may be missed by echocardiography.
Schoensiegel
Frank
F
Department of Medicine III, Otto-Meyerhof-Zentrum, University of Heidelberg, Heidelberg, Germany.
Bekeredjian
Raffi
R
Schrewe
Anja
A
Weichenhan
Dieter
D
Frey
Norbert
N
Katus
Hugo A
HA
Ivandic
Boris T
BT
D000375:Aging / Q000097:blood; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D009202:Cardiomyopathies / Q000097:blood / Q000235:genetics / Q000473:pathology; D002352:Carrier Proteins / Q000235:genetics; D004195:Disease Models, Animal; D005260:Female; D006331:Heart Diseases / Q000097:blood* / Q000235:genetics / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D008840:Microfilament Proteins; D009124:Muscle Proteins / Q000172:deficiency / Q000235:genetics; D053495:Osteopontin / Q000097:blood*; D010641:Phenotype; D049031:Sarcoglycans / Q000172:deficiency / Q000235:genetics; D013045:Species Specificity; D020257:Ventricular Remodeling
D015415:Biomarkers; D002352:Carrier Proteins; D008840:Microfilament Proteins; D009124:Muscle Proteins; C523646:Myoz2 protein, mouse; D049031:Sarcoglycans; C506896:Spp1 protein, mouse; D053495:Osteopontin; D009320:Atrial Natriuretic Factor